N-SIDE Life Sciences

🌍 The rise of Generative AI is transforming industries worldwide, but did you know it’s just one piece of the AI puzzle? In clinical supply chains, different AI methods can play a huge role in boosting efficiency, accuracy, and innovation. Check out our latest article to explore how Generative AI fits into the bigger picture of clinical supply—and why other AI techniques may be equally, if not more, effective! 🔗 https://hubs.la/Q02X56TK0 This article is the first in our new series on AI in Clinical Supply Chain written by N-SIDE's Strategy Expert Amaury Jeandrain. Don't hesitate to subscribe to be the first one to know when the next episode is out! #genAI #pharma #clinicalsupply #lifesciences #innovation

🌟 Weekly Voices of Victory 🌟 This week, we're turning the spotlight to Antoine Remiot, our incredible Business Development and Partnerships Director 🎉 Antoine perfectly embodies our N-SIDE values of collaboration, commitment and passion. You might have already met him at one of the numerous industry events we attend. During these events, he always makes N-SIDE shine and help further innovation in clinical supply chain management with other CTS experts ✨ ➡ Don't hesitate to share your successes with us! Let's celebrate the amazing impact our community is achieving daily 🤜 🤛 #WeeklyVoicesofVictory #lifesciences #clinicalsupplychain

𝐖𝐞 𝐚𝐬𝐤𝐞𝐝 𝐀𝐈: 𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐭𝐨𝐩 3️⃣ 𝐚𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐨𝐟 𝐬𝐢𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐬𝐮𝐩𝐩𝐥𝐲 𝐜𝐡𝐚𝐢𝐧? 𝐇𝐞𝐫𝐞'𝐬 𝐰𝐡𝐚𝐭 𝐢𝐭 𝐬𝐚𝐢𝐝: 1️⃣ 𝐃𝐞𝐦𝐚𝐧𝐝 𝐚𝐧𝐝 𝐈𝐧𝐯𝐞𝐧𝐭𝐨𝐫𝐲 𝐎𝐩𝐭𝐢𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧: Simulations can be used to model patient enrollment, dosing schedules, and site variability. This could help identify the right balance between avoiding overstocking and preventing shortages, ensuring smooth trial operations and reducing waste. 2️⃣ 𝐑𝐢𝐬𝐤 𝐌𝐢𝐭𝐢𝐠𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐂𝐨𝐧𝐭𝐢𝐧𝐠𝐞𝐧𝐜𝐲 𝐏𝐥𝐚𝐧𝐧𝐢𝐧𝐠: Simulations could allow supply chain teams to test "what-if" scenarios, such as shipping delays or patient dropouts, enabling them to prepare robust contingency plans and proactively address potential disruptions. 3️⃣ 𝐂𝐨𝐬𝐭 𝐚𝐧𝐝 𝐄𝐧𝐯𝐢𝐫𝐨𝐧𝐦𝐞𝐧𝐭𝐚𝐥 𝐈𝐦𝐩𝐚𝐜𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬: Simulations can assess the financial and environmental impact of various supply chain strategies. This might support decisions that lower costs while also reducing the carbon footprint of clinical trials. 👉 At N-SIDE, these aren’t just theoretical possibilities—they are exactly the kind of challenges we tackle with our native Supply App simulation & optimization algorithm. Curious to learn more? Let’s connect!

A couple of weeks ago we had the pleasure of attending the Arena International Events Group Clinical Trial Supply Event Series East Coast 🤩 Once again, we wanted to thank Isaac Greenslade, PMP from Sanofi for joining N-SIDE's Pauline Deplasse to discuss Sanofi's impressive transformation of their clinical supply chain. In the last years, they have managed to replace over 2,500 Excel files with a single, cohesive ecosystem focused on end-to-end performance. Thanks to this single source of truth, they have benefited from: - Improved productivity and agility - Enhanced transparency between departments - Empowered data-driven decision-making Stay tuned because we will be able to share more insights from this great discussion with you in the coming weeks 🚀

🌟 Weekly Voices of Victory 🌟 Today let's turn the spotlight to Julien Vandenbosch, a remarkable Senior Integration Specialist at N-SIDE 🤩 As an integration specialist, Julien ensures our customers can have a smooth data integration with our products. We always thrive on delivering the most accurate results possible and to do that we need to have the right data. As Julien says, it's incredibly rewarding to see the benefits of a strong collaboration between all stakeholders 💪 ➡ Share your successes with us! Let's celebrate the amazing impact our community is achieving daily 🤜 🤛 #WeeklyVoicesofVictory #lifesciences #clinicalsupplychain

Managing clinical trials is complex, it's a well-known fact. Ensuring patient treatment continuity, while anticipating uncertainties and working under budget constraints are common challenges. Collaboration between all stakeholders is key to navigating these challenges. Vendors are experts in their fields, and strong partnerships can drive efficiency and innovation in clinical supply chains. Read on to learn what fuels effective cooperation 👇

📸 A little behind the scenes of the N-SIDE team at industry events 🤩 Shout out to our incredible team members on the ground connecting with peers and forging relationships with clinical supply chain experts around the world! Recently, Yoni Van den Branden, Amaury Jeandrain, Laurent Verdickt and Antoine Remiot attended the GCSG - Global Clinical Supplies Group annual conference in Malta, while Maxime Derep, Dan Caramore, and Jake Levine represented the company at the Informa Connect IRT event in Boston. Earlier this week, our US team also was at the Clinical Trial Supply Event Series in King of Prussia! 🚀 Looking forward to meeting you all at our next events 👋

The 2024 Citeline Clinical Pharma R&D Annual Review offers pretty valuable insights for our industry! 📑 We highly recommend reading the full (free) report for a deeper dive 👉 https://lnkd.in/etdbpuxk On our side, we have identified 3 trends that will shape clinical supply chain management in the years ahead ⬇️ 1️⃣ Increasing Number of Drugs and Trials With more trials launching each year, competition for patients is intensifying on certain indications, and the pharmaceutical industry is starting to tackle rarer diseases. This leads to slower recruitment and longer trial durations. For clinical supply chains, this means added complexity and increased drug waste to cover for uncertain recruitment rates. 2️⃣ Increased Focus on Oncology Oncology continues to dominate R&D, but this brings unique challenges for clinical supply chain management. Trials often involve complex protocols, sensitive materials (e.g., cold chain requirements), and costly comparators. Additionally, the industry has faced shortages in chemotherapies over the past few years, further complicating supply planning. 3️⃣ Growth of Biologic Drugs and Cell & Gene Therapies Biologic drugs are sensitive, costly, and have specific handling requirements. This adds even more layers of complexity to the clinical supply chain, demanding precise planning and waste management to use these high-value treatments effectively. At N-SIDE, we specialize in managing the complexities of clinical trial supply chains, mitigating drug shortages and reducing waste. Don't hesitate to reach out to learn how we can help you navigate these evolving trends.

"Optimization is amazing but it's theoretical until someone can make it happen." During our latest webinar, Amaury Jeandrain emphasized why a strong relationship with other vendors active in the clinical supply chain landscape is key. You can read our newest blog post to dive into key insights shared by experts from Clinigen Clinical Supplies Management, N-SIDE, and Suvoda during this webinar 👉 https://hubs.la/Q02WqCN10 Vendors aren't just service providers—they’re strategic partners. Their expertise can lead to cost reduction, improved patient outcome, and seamless navigation of unexpected challenges. And the better they know each other, the stronger the collaboration will be. We are all working towards the same goal after all 💪🚀

Don't miss Sanofi's Isaac Greenslade, PMP and N-SIDE's Pauline Deplasse next week at the Clinical Trial Supply Event Series East Coast! Join them on November 5th at 10 AM to learn more about Sanofi's impressive journey to improve their clinical supply chain's performance 🎯 🚀